CMD63 CAR T-cell
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMD63 CAR T-cell, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL) [Phase 1]